115 related articles for article (PubMed ID: 36585772)
1. Empagliflozin: Validation of Stability-Indicating LC Method and in silico Toxicity Studies.
da Silva AT; Brabo GR; Porto DDS; da Silva Jonco J; Bajerski L; Paula FR; Paim CS
J Chromatogr Sci; 2024 Feb; 62(2):132-139. PubMed ID: 36585772
[TBL] [Abstract][Full Text] [Related]
2. Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA.
Heleno Ferreira RB; Duarte JA; Ferreira FD; de Oliveira LFS; Machado MM; Malesuik MD; Paula FR; Steppe M; Schapoval EES; Paim CS
J Anal Methods Chem; 2019; 2019():7534609. PubMed ID: 30944754
[TBL] [Abstract][Full Text] [Related]
3. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS Determination of Empagliflozin and Metformin.
Ayoub BM; Mowaka S
J Chromatogr Sci; 2017 Aug; 55(7):742-747. PubMed ID: 28383657
[TBL] [Abstract][Full Text] [Related]
5. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
[TBL] [Abstract][Full Text] [Related]
6. Validated Liquid Chromatographic Method for the Determination of (Canagliflozin, Dapagliflozin or Empagliflozin) and Metformin in the Presence of (1-Cyanoguanidine).
Hassib ST; Taha EA; Elkady EF; Barakat GH
J Chromatogr Sci; 2019 Aug; 57(8):697-707. PubMed ID: 31240304
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media.
Ibrahim A; Wang F; Gary Hollenbeck R; Martinez MN; Fahmy R; Hoag SW
AAPS PharmSciTech; 2023 Oct; 24(7):211. PubMed ID: 37821763
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of potential genotoxic impurities in metformin hydrochloride and empagliflozin tablets through ultra-performance liquid chromatographymass spectrometry.
Xiao T; Hu X; Chen Y; Lin H
J Pharm Biomed Anal; 2024 Apr; 241():116000. PubMed ID: 38280234
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
[TBL] [Abstract][Full Text] [Related]
10. Validation of a novel UPLC-MS/MS method for estimation of metformin and empagliflozin simultaneously in human plasma using freezing lipid precipitation approach and its application to pharmacokinetic study.
Abou-Omar MN; Kenawy M; Youssef AO; Alharthi S; Attia MS; Mohamed EH
J Pharm Biomed Anal; 2021 Jun; 200():114078. PubMed ID: 33901756
[TBL] [Abstract][Full Text] [Related]
11. A sensitive LC-MS/MS method for the determination of potential genotoxic impurities in Cinnarizine.
Mullangi S; Ravindhranath K; Yarala MR; Panchakarla RK
Ann Pharm Fr; 2023 Jan; 81(1):74-82. PubMed ID: 35792147
[TBL] [Abstract][Full Text] [Related]
12. A rapid LC-PDA method for the simultaneous quantification of metformin, empagliflozin and linagliptin in pharmaceutical dosage form.
Gollu G; Gummadi S
Ann Pharm Fr; 2022 Jan; 80(1):48-58. PubMed ID: 34157314
[TBL] [Abstract][Full Text] [Related]
13. Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography-mass spectrometry and application to pharmacokinetics.
Wattamwar T; Mungantiwar A; Halde S; Pandita N
Eur J Mass Spectrom (Chichester); 2020 Apr; 26(2):117-130. PubMed ID: 31575298
[TBL] [Abstract][Full Text] [Related]
14. The application of quality by design in the development of the liquid chromatography method to determine empagliflozin in the presence of its organic impurities.
Manoel JW; Primieri GB; Bueno LM; Wingert NR; Volpato NM; Garcia CV; Scherman Schapoval EE; Steppe M
RSC Adv; 2020 Feb; 10(12):7313-7320. PubMed ID: 35493885
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products.
Ragham PK; Chandrasekhar KB
J Pharm Biomed Anal; 2016 Jun; 125():122-9. PubMed ID: 27018505
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
[TBL] [Abstract][Full Text] [Related]
18. A developed and validated stability-indicating reverse-phase high performance liquid chromatographic method for determination of cefdinir in the presence of its degradation products as per International Conference on Harmonization guidelines.
Hamrapurkar P; Patil P; Phale M; Gandhi M; Pawar S
Pharm Methods; 2011 Jan; 2(1):15-20. PubMed ID: 23781424
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study.
Chinta SR; Chintala V; Nandimalla V; Ch R; Ediga SG; Kowtharapu LP; Katari NK
J AOAC Int; 2024 Jan; 107(1):31-39. PubMed ID: 37758265
[TBL] [Abstract][Full Text] [Related]
20. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
